Track topics on Twitter Track topics that are important to you
The recently approved disease-modifying therapy is expected to find a niche for patients with multiple sclerosis who fail other agents.
Medscape Medical News
Original Article: ORACLE-MS: Cladribine Effective in MS SubgroupsNEXT ARTICLE
Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...